Cargando…
Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide
We report an analysis of in vitro and in vivo drug release from an in situ formulation consisting of triamcinolone acetonide (TR) and poly(d,l-lactide-co-glycolide) (PLGA) and the additives glycofurol (GL) and hydroxyapatite nanoparticles (HA). We found that these additives enhanced drug release rat...
Autores principales: | Koocheki, Saeid, Madaeni, Sayed Siavash, Niroomandi, Parisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090279/ https://www.ncbi.nlm.nih.gov/pubmed/21589650 http://dx.doi.org/10.2147/IJN.S18045 |
Ejemplares similares
-
Transdermal permeability of triamcinolone acetonide lipid nanoparticles
por: Qin, Zhenmiao, et al.
Publicado: (2019) -
Triamcinolone acetonide acetate
por: Lu, Xiao, et al.
Publicado: (2011) -
A randomized, phase IIa study to assess the systemic exposure of
triamcinolone acetonide following injection of extended-release triamcinolone
acetonide or traditional triamcinolone acetonide into both knees of patients
with bilateral knee osteoarthritis
por: Kivitz, Alan, et al.
Publicado: (2019) -
Biopharmaceutical Study of Triamcinolone Acetonide Semisolid Formulations for Sublingual and Buccal Administration †
por: Márquez Valls, Marta, et al.
Publicado: (2021) -
Sustained Release of Triamcinolone Acetonide from an Intratympanically Applied Hydrogel Designed for the Delivery of High Glucocorticoid Doses
por: Honeder, Clemens, et al.
Publicado: (2014)